PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1490
https://www.valueinhealthjournal.com/article/S1098-3015(12)03203-2/fulltext
Title :
PRM26 The Use of Claims-Based CHA2DS2-VASc and ATRIA Scores to Predict Stroke/Systemic Embolism and Bleeding Rates Among Anticoagulated Patients With Atrial Fibrillation (AFIB) in a Pharmacy-Benefit Management (PBM) Environment
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03203-2&doi=10.1016/j.jval.2012.08.1490
First page :
A464
Section Title :
Research on Methods
Open access? :
No
Section Order :
986